Vanda Pharmaceuticals
VNDA
VNDA
131 hedge funds and large institutions have $812M invested in Vanda Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 40 increasing their positions, 45 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
3.66% more ownership
Funds ownership: 90.97% → 94.63% (+3.7%)
11% less repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 45
54% less call options, than puts
Call options by funds: $1.01M | Put options by funds: $2.18M
Holders
131
Holding in Top 10
3
Calls
$1.01M
Puts
$2.18M
Top Buyers
| 1 | +$51.8M | |
| 2 | +$23M | |
| 3 | +$21.7M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$20.3M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$16.1M |
Top Sellers
| 1 | -$14.7M | |
| 2 | -$8.22M | |
| 3 | -$5.07M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$4.23M |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$2.94M |